1. Six-Gene Signature for Differential Diagnosis and Therapeutic Decisions in Non-Small-Cell Lung Cancer—A Validation Study
   Radoslaw Charkiewicz et al, 2024, International Journal of Molecular Sciences CrossRef
2. Lung cancer prognostic index: a risk score to predict overall survival after the diagnosis of non-small-cell lung cancer
   Marliese Alexander et al, 2017, British Journal of Cancer CrossRef
3. Impact of Results of TTF-1 Immunostaining on Efficacy of Platinum-Doublet Chemotherapy in Japanese Patients with Nonsquamous Non-Small-Cell Lung Cancer
   Akira Nakao et al, 2022, Journal of Clinical Medicine CrossRef
4. Lung cancer survival and sex-specific patterns in Portugal: A population-based analysis
   T. Guerreiro et al, 2023, Pulmonology CrossRef
5. miRNA-Seq Tissue Diagnostic Signature: A Novel Model for NSCLC Subtyping
   Radoslaw Charkiewicz et al, 2023, International Journal of Molecular Sciences CrossRef
6. Hyper-phosphorylation of Rb S249 together with CDK5R2/p39 overexpression are associated with impaired cell adhesion and epithelial-to-mesenchymal transition: Implications as a potential lung cancer grading and staging biomarker
   Jaileene Pérez-Morales et al, 2018, PLOS ONE CrossRef
7. Patterns of Extrathoracic Metastasis in Lung Cancer Patients
   Hyung Kyu Park et al, 2022, Current Oncology CrossRef
8. Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes
   Andrea Mogavero et al, 2023, Life CrossRef
9. Advances in cytology of lung cancer
   Deepali Jain et al, 2021, Seminars in Diagnostic Pathology CrossRef
10. Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced Nonsquamous NSCLC
    Yuto Terashima et al, 2023, JTO Clinical and Research Reports CrossRef